Medical Writing Authors and Authorship GPP3 – what is it, why is it necessary and what is new?
emwa-spring-2016png

Volume 25, Issue 1 - Authors and Authorship

GPP3 – what is it, why is it necessary and what is new?

Abstract

The good publication practice for pharmaceutical companies (GPP) guidelines were first published in 2003, then revised in 2009 (GPP2) and most recently in 2015 (GPP3). The latest version reflects the changes that have occurred in legislation concerning dissemination of data from clinical trials, mainly focussed on the pharmaceutical industry. These guidelines are intended to serve as a basis for publication professionals to establish transparent and ethical working practices within the pharmaceutical industry. The need for such guidance and the main differences in the latest version are introduced.

Download the full article

References

  1. Anderson ML, Chiswell K, Peterson ED, et al. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med 2015;372:1031–9.
  2. Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin 2003;19(3):149–54.
  3. Graf C, Battisti WP, Dan Bridges D, et al. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330.
  4. Battisti WP, Wager E, Baltzer L, et al. Good Publication Practice for communicating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163(6):461–4.
  5. International Committee of Medical Journal Editors. Recommendations [cited January 5, 2016] Available from: http://www.icmje.org/recommendations/

Search

Articles

Authors and Authorship
Letter from the Editor
President’s Message
Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014)
The sun never sets on transparency
GPP3 – what is it, why is it necessary and what is new?
Attribution, advocacy, disposable authors, corporate ghosts and cultural assimilation: new themes in the ethical critique of commercial medical literature
Perspective from a leading scientific author: An interview with Professor Ruth Roberts on authors and authoring
Authorship of clinical trial documents
Project management in medical publication writing: A less explored avenue in pharmaceutical companies and clinical research organisations
Never say never! Returning to full-time employment after freelancing
Fifth EMWA freelance business survey
Journal Watch
In the Bookstores
The Webscout
Regulatory Writing: Authorship issues in regulatory documents
English Grammar and Style
Medical Communication
Lingua Franca and Beyond
Gained in Translation
Medical Writing Teaching
Profile: An interview with Phil Leventhal
EMWA’s 2016 Webinar Programme
Out on our own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

  • Victoria White (Tampa, Florida, USA)
show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: